Antioxidant Activity of Bovine Colostrum in the Colon of a Mouse Model of TNBS-Induced Colitis
Open Access
- 18 February 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (2) , 232
Abstract
(1) Background: Bovine colostrum (BC) is the initial milk produced by cows after giving birth and has revealed significant potential in helping various health conditions, particularly in diseases of the gastrointestinal tract, such as inflammatory bowel disease, including colitis. BC is renowned for its rich composition of components that strengthen the immune system. Inflammatory bowel diseases, including colitis, are characterized by elevated oxidative stress, leading to tissue damage and exacerbated symptoms. The aim of this study was to explore the potential antioxidant activity of bovine colostrum in the context of a mouse model of trinitrobenzene sulfonic acid-induced colitis. The effectiveness of BC in mitigating oxidative stress and its effects on colitis was evaluated. (2) Methods: Mice were divided into two groups, one group received BC by gavage for 21 days, the other group received saline solution; after 21 days one half of each of the two groups of mice were treated intrarectally with trinitrobenzene sulfonic acid to induce colitis. Colon samples were processed by immunocytochemical methods. The immunoreactivity of the main antioxidant enzymes, (i) catalase (CAT), (ii) superoxide dismutase 1 (SOD1), (iii) superoxide dismutase 2 (SOD2) and glutathione peroxidase 4 (GPX4), at the colon level was analyzed. (3) Results: The results showed positive immunoreactivity of catalase and SOD2 activities of BC in the colon of animals after induction of inflammation. (4) Conclusions: The findings have the potential to suggest new strategies for the management of gastrointestinal disorders related to oxidative stress. Furthermore, the knowledge gained could contribute to the development of functional foods or supplements specifically designed for the management of colitis. Future studies will be aimed at identifying the bioactive fractions of BC to study the mechanisms underlying its actions, as well as to trace which populations can benefit most from colostrum consumption, in addition to subjects with gastrointestinal disorders.Keywords
This publication has 48 references indexed in Scilit:
- Bovine Colostrum in Increased Intestinal Permeability in Healthy Athletes and Patients: A Meta-Analysis of Randomized Clinical TrialsDigestive Diseases and Sciences, 2024
- Antioxidant, antimicrobial and anticarcinogenic activities of bovine milk proteins and their hydrolysates - A reviewInternational Dairy Journal, 2022
- Bovine colostrum: A source of bioactive compounds for prevention and treatment of gastrointestinal disordersNFS Journal, 2021
- Nutritional attributes of bovine colostrum components in human health and disease: A comprehensive reviewFood Bioscience, 2021
- SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitisRedox Biology, 2020
- The TNBS-induced colitis animal model: An overviewAnnals of Medicine & Surgery, 2016
- ROS Function in Redox Signaling and Oxidative StressCurrent Biology, 2014
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel diseaseBiochemical Pharmacology, 2013
- Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell DeathCell Metabolism, 2008
- Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel diseaseClinical Nutrition, 2008